$0.7790
0.0811.29%
At close: -
$0.6986
-0.08-10.32%
After Hours: 5:30 PM EDT
Comments
Loading...
Latest ProMIS Neurosciences Stock News | NASDAQ:PMN | Benzinga
Get the latest news on ProMIS Neurosciences stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on ProMIS Neurosciences performance
Categories: All
Wednesday, February 26, 2025
Tuesday, February 25, 2025
Friday, January 10, 2025
Thursday, November 14, 2024
Wednesday, October 30, 2024
Thursday, September 19, 2024
Thursday, August 29, 2024
Tuesday, August 27, 2024
Monday, August 19, 2024
Monday, August 12, 2024
Thursday, August 08, 2024
Tuesday, August 06, 2024
Tuesday, July 30, 2024
Friday, July 26, 2024
Tuesday, May 14, 2024
Monday, April 15, 2024
Tuesday, April 02, 2024
Monday, March 11, 2024
Monday, January 22, 2024
Friday, January 19, 2024
Wednesday, January 03, 2024
Tuesday, November 14, 2023
Tuesday, October 03, 2023
Friday, September 22, 2023
Tuesday, August 22, 2023
- ProMIS Neurosciences shares are trading highe...
- Crude Oil Falls; Dick's Sporting Goods Earnings Miss Views
- Why Macy's Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- Why ProMIS Neurosciences Shares Are Trading Higher By 33%; Here Are 20 Stocks Moving Premarket
- Market-Moving News for August 22nd
Monday, August 21, 2023
Monday, August 14, 2023
Wednesday, August 09, 2023
Tuesday, July 18, 2023
Monday, July 17, 2023
- Crude Oil Falls; GreenPower Motor Company Shares Spike Higher
- Why ProMIS Neurosciences Stock Surged Today
- Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Nasdaq Gains 100 Points; Guaranty Bancshares Posts Upbeat Results
- ProMIS Neurosciences shares are trading highe...
- US Stocks Edge Higher; NY Empire State Manufacturing Index Falls In July
- ProMIS Neurosciences Shares Resume Trade
- ProMIS Neurosciences Shares Halted On Circuit...
- Reported Earlier, ProMIS Showcases Preclinical Data At The Alzheimer's Association International Conference 2023 On Computationally-Derived Antibody And Vaccine From Alzheimer's Pipeline